Envestnet Asset Management Inc Coherus Bio Sciences, Inc. Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.59 - $3.85 $16,310 - $39,493	-10,258 Reduced 46.31%	11,892 $39,000
Q3 2023 Nov 13, 2023	BUY	$3.74 - $5.45 $21,905 - $31,920	5,857 Added 35.95%	22,150 $82,000
Q2 2023 Aug 04, 2023	SELL	$3.79 - $8.3 $3,183 - $6,972	-840 Reduced 4.9%	16,293 $69,000
Q1 2023 May 11, 2023	BUY	$5.89 - $10.52 $6,797 - $12,140	1,154 Added 7.22%	17,133 $117,000
Q4 2022 Feb 07, 2023	SELL	$5.69 - $10.07 $46,726 - $82,694	-8,212 Reduced 33.95%	15,979 $126,000
Q3 2022 Nov 10, 2022	BUY	$7.17 - $13.87 $45,493 - $88,005	6,345 Added 35.55%	24,191 $232,000
Q2 2022 Aug 03, 2022	SELL	$5.86 - $13.23 $6,574 - $14,844	-1,122 Reduced 5.92%	17,846 $129,000
Q1 2022 May 04, 2022	SELL	$10.92 - $16.41 $78,853 - $118,496	-7,221 Reduced 27.57%	18,968 $245,000
Q4 2021 Feb 04, 2022	BUY	$15.81 - $18.99 $49,580 - $59,552	3,136 Added 13.6%	26,189 $418,000
Q3 2021 Oct 07, 2021	BUY	$12.68 - $17.79 $29,747 - $41,735	2,346 Added 11.33%	23,053 $370,000
Q2 2021 Aug 04, 2021	BUY	$12.95 - $15.41 $3,328 - $3,960	257 Added 1.26%	20,707 $286,000
Q1 2021 May 04, 2021	SELL	$14.42 - $21.39 $2,494 - $3,700	-173 Reduced 0.84%	20,450 $299,000
Q4 2020 Feb 02, 2021	BUY	$16.56 - $18.94 $113,999 - $130,382	6,884 Added 50.11%	20,623 $358,000
Q3 2020 Oct 09, 2020	SELL	$17.41 - $19.89 $8,635 - $9,865	-496 Reduced 3.48%	13,739 $252,000
Q2 2020 Jul 08, 2020	SELL	$14.43 - $19.16 $515,757 - $684,816	-35,742 Reduced 71.52%	14,235 $254,000
Q1 2020 Apr 23, 2020	BUY	$11.67 - $22.53 $55,992 - $108,098	4,798 Added 10.62%	49,977 $811,000
Q4 2019 Feb 11, 2020	BUY	$16.33 - $21.37 $40,433 - $52,912	2,476 Added 5.8%	45,179 $813,000
Q3 2019 Oct 17, 2019	BUY	$16.3 - $23.37 $696,058 - $997,969	42,703 New	42,703 $865,000
Q3 2018 Nov 14, 2018	SELL	$14.45 - $20.25 $18,221 - $25,535	-1,261 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$10.25 - $17.45 $2,142 - $3,647	209 Added 19.87%	1,261 $18,000
Q1 2018 May 09, 2018	BUY	$9.1 - $13.7 $4,695 - $7,069	516 Added 96.27%	1,052 $12,000
Q4 2017 Feb 20, 2018	BUY	$8.35 - $14.4 $4,475 - $7,718	536	536 $5,000

Others Institutions Holding CHRS

# of Institutions

135

Shares Held

77.9M

Call Options Held

40.7K

Put Options Held

50.1K

Black Rock Inc. New York, NY

11.8M
Shares

$18.5 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.3M
Shares

$17.8 Million
0.0% of portfolio
Rubric Capital Management LP New York, NY

10.4M
Shares

$16.3 Million
0.3% of portfolio
Kohlberg Kravis Roberts & Co. L.P. New York, NY

3.04M
Shares

$4.77 Million
0.18% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

2.86M
Shares

$4.49 Million
0.0% of portfolio

View Full List

About Coherus BioSciences, Inc.

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

More about CHRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account